Filter by: Subject

Filter by: Subject

Results Per Page:

South Africa (SA) (20)
Mesenchymal stromal/stem cells (MSCs) (9)
Treatment (6)
Gene therapy (5)
Human immunodeficiency virus (HIV) (5)
Cell therapy (4)
Human leukocyte antigen (HLA) (4)
South Africa (4)
Cystic fibrosis (CF) (3)
Disease (3)
Informed consent (3)
Pharmacogenetics (3)
Stem cells (3)
Adipocyte differentiation (2)
Adipose-derived stromal cells (ASCs) (2)
Africa (2)
African populations (2)
Angiogenesis (2)
Bleomycin (2)
Bone marrow (2)
Carcinogenesis (2)
Cell migration (2)
Cell-based therapy (2)
Consumer Protection Act 68 of 2008 (CPA) (2)
Cord blood banking (2)
CYP2D6 (2)
Deoxyribonucleic acid (DNA) (2)
Ethics (2)
Extracellular matrix (2)
Genetic therapy (2)
Genomics (2)
Haematopoietic stem cell transplantation (HSCT) (2)
Hemangioma (2)
Human genome (2)
Human tissue (2)
Human tissue legislation (2)
In vitro (2)
Mitochondrial disease (2)
Mitochondrial DNA (mtDNA) (2)
Next generation sequencing (NGS) (2)
Obesity (2)
OncoScan analysis (2)
Oral cancer (2)
Patients (2)
Pharmacogenomics (2)
Pharmacokinetics (2)
Privacy (2)
Reactive oxygen species (2)
Reactive oxygen species (ROS) (2)
Regenerative medicine (2)
Stem cell research (2)
Stem cell therapy (2)
Stem cell transplantation (2)
Ubuntu (2)
Umbilical cord blood (UCB) (2)
ABCB1 gene (1)
Academic understanding (1)
Acquired immune deficiency syndrome (AIDS) (1)
Activity score (1)
Activity score system (1)
Acute myeloid leukaemia (1)
Acute myeloid leukemia (AML) (1)
Additive solution (1)
Adherence (1)
Adipogenesis (1)
Adipogenic differentiation (1)
Adipose derived stromal/stem cells (ASCs) (1)
Adipose tissue (1)
Adipose tissuederived (1)
Adipose-derived stromal cell (ASC) (1)
Adipose-derived stromal cells (1)
Adipose-derived stromal/stem cells (ASCs) (1)
Adipose‐derived stromal cells (ASCs) (1)
Adult patients (1)
Adult stem cells (1)
Adverse drug reaction (1)
Adverse drug reactions (1)
Adverse drug reactions (ADRs) (1)
Aerobic fitness (1)
Africa epidemiology (1)